gms | German Medical Science

Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

09.09. - 12.09.2020, virtuell

Spondyloarthritiden

Meeting Abstract (SpA.01)

Management von Patienten mit axialer Spondylarthritis: Ist die Selbstüberwachung mit einer Smartphone-App machbar? Eine Proof-of-Concept-Studie

Kiltz U, Kempin R, Richter J, Schlegel A, Baraliakos X, Tsiami S, Andreica I, Bühring B, Kiefer D, Braun J
[Full Text]
Meeting Abstract (SpA.18)

Effects of anti-TNF-therapy on osteoblastic activity in ankylosing spondylitis – results from a prospective study using PET-MRI of SIJ and spine

Baraliakos X, Tsiami S, Rischpler C, Bruckmann NM, Fendler W, Kirchner J, Herrmann K, Sawicki LM, Braun J
[Full Text]
Meeting Abstract (SpA.19)

The degree of bone marrow edema as detected by magnetic resonance imaging in the sacroiliac joints and the spine suspicious of axial spondyloarthritis in the general population is associated with different factors

Baraliakos X, Richter A, Feldmann D, Ott A, Buelow R, Schmidt C, Braun J
[Full Text]
Meeting Abstract (SpA.28)

Frequency of disease flares under long-term anti-TNF therapy in patients with early axial spondyloarthritis: results from the etanercept versus sulfasalazine in early axial spondyloarthritis trial

Proft F, Torgutalp M, Weiß A, Protopopov M, Rios Rodriguez V, Haibel H, Hermann KG, Althoff C, Behmer O, Sieper J, Poddubnyy D
[Full Text]
Meeting Abstract (SpA.29)

Long-term Clinical Outcome of Anti-TNF Treatment in patients with Early Axial Spondyloarthritis: 10-year Data of the Etanercept vs. Sulfasalazin in Early Axial Spondyloarthritis Trial

Proft F, Torgutalp M, Weiß A, Protopopov M, Rios Rodriguez V, Haibel H, Behmer O, Sieper J, Poddubnyy D
[Full Text]
Meeting Abstract (SpA.30)

Clinical course of early axial spondyloarthritis over ten years: long-term results from the German Spondyloarthritis Inception Cohort

Poddubnyy D, Rios Rodriguez V, Torgutalp M, Verba M, Callhoff J, Protopopov M, Proft F, Rademacher J, Haibel H, Sieper J, Rudwaleit M
[Full Text]
Meeting Abstract (SpA.32)

Treatment response to biological disease-modifying anti-rheumatic drugs is associated with favorable changes of the body composition in patients with ankylosing spondylitis

Rios Rodriguez V, Protopopov M, Proft F, Rademacher J, Muche B, Weber AK, Lüders S, Haibel H, Verba M, Sieper J, Poddubnyy D
[Full Text]
Meeting Abstract (SpA.33)

Impact of body composition measures on the response to biological disease-modifying anti-rheumatic drugs in patients with ankylosing spondylitis

Rios Rodriguez V, Protopopov M, Proft F, Rademacher J, Muche B, Weber AK, Lüders S, Haibel H, Verba M, Sieper J, Poddubnyy D
[Full Text]
Meeting Abstract (SpA.34)

The presence of spondyloarthritis is associated with higher clinical disease activity in patients with early Crohn’s disease: results of a prospective cohort study

Rios Rodriguez V, Protopopov M, Proft F, Lüders S, Rademacher J, Haibel H, Verba M, Sieper J, Sonnenberg E, Kredel LI, Schumann M, Siegmund B, Poddubnyy D
[Full Text]
Meeting Abstract (SpA.35)

Unterschiede zwischen Männern und Frauen mit Psoriasis-Arthritis und deren Korrelation mit der Hautbeteiligung: eine Querschnittsanalyse der RABBIT-SpA-Patienten

Regierer A, Weiß A, Behrens F, Feuchtenberger M, Schett G, Baraliakos X, Zink A, Strangfeld A
[Full Text]
Meeting Abstract (SpA.36)

Gibt es ein „Window of Opportunity“ bei der frühen Psoriasisarthritis? Daten aus einer rheumatologischen Praxis

Werner S, Vlachou M, Langer HE, Chatelain R
[Full Text]
Meeting Abstract (SpA.37)

Depressive Symptomatik bei axSpA-Patienten ist mit hoher Krankheitsaktivität und schlechtem Funktionsstatus assoziiert: eine Querschnittsanalyse aus RABBIT-SpA

Regierer A, Weiß A, Baraliakos X, Poddubnyy D, Schwarze I, Braun J, Sieper J, Zink A, Strangfeld A
[Full Text]
Meeting Abstract (SpA.40)

Fluorescence-optical imaging technique in detection of psoriatic arthritis in psoriasis patients

Köhm M, Ohrndorf S, Roßmanith T, Backhaus M, Burmester G, Wassenberg S, Köhler B, Burkhardt H, Behrens F
[Full Text]
Meeting Abstract (SpA.42)

Extra-articular and non-axial manifestations in patients with early axial spondyloarthritis from the CORSAR cohort during 3 years of follow-up, managed according to the T2T strategy

Rumiantceva D, Erdes S, Dubinina T, Krichevskaya O, Demina A
[Full Text]
Meeting Abstract (SpA.43)

Impact of Methotrexate on disease pattern in active psoriatic arthritis patients eligible for a randomized clinical trial with Ustekinumab (UST): Comparative baseline data from multicentre investigator-initiated MUST trial

Rossmanith T, Köhm M, Kiltz U, Rech J, Burmester GR, Kellner H, Bulczak-Schadendorf A, Foldenauer AC, Burkhardt H, Behrens F
[Full Text]
Meeting Abstract (SpA.44)

Müdigkeit und Erschöpfung bei Psoriasis-Arthritis – Prävalenz und Bedeutung in der täglichen rheumatologischen Praxis

Werner S, Vigener-Buxel C, Langer HE, Chatelain R
[Full Text]